The Emerging Role of c-Met in Carcinogenesis and Clinical Implications as a Possible Therapeutic Target
A. Faiella(Ospedale Antonio Cardarelli), Livia Onofrio(University of Naples Federico II), Ferdinando Riccardi(Ospedale Antonio Cardarelli), Giacomo Cartenì(Ospedale Antonio Cardarelli), Martina Chiurazzi(Federico II University Hospital)
Cited by 50
Related Papers
First-Line Erlotinib Followed by Second-Line Cisplatin-Gemcitabine Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The TORCH Randomized Trial
|Journal of Clinical Oncology|2012|234
Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial
|Journal of Clinical Oncology|2017|186
Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study
|The Journal of Clinical Endocrinology & Metabolism|2019|180
Real-World Study of Everolimus in Advanced Progressive Neuroendocrine Tumors
|The Oncologist|2014|103